Equities

West Pharmaceutical Services Inc

West Pharmaceutical Services Inc

Actions
  • Price (EUR)300.40
  • Today's Change-0.50 / -0.17%
  • Shares traded4.00
  • 1 Year change-2.05%
  • Beta--
Data delayed at least 15 minutes, as of Nov 08 2024 16:25 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

SmartText is unavailable
Gross margin34.87%
Net profit margin16.81%
Operating margin19.86%
Return on assets13.02%
Return on equity17.78%
Return on investment15.16%
More ▼

Cash flow in USDView more

In 2023, West Pharmaceutical Services Inc did not generate a significant amount of cash. However, the company earned 776.50m from its operations for a Cash Flow Margin of 26.32%. In addition the company used 368.70m on investing activities and also paid 459.60m in financing cash flows.
Cash flow per share8.57
Price/Cash flow per share37.01
Book value per share37.96
Tangible book value per share36.29
More ▼

Balance sheet in USDView more

West Pharmaceutical Services Inc has a Debt to Total Capital ratio of 6.95%, a higher figure than the previous year's 5.30%.
Current ratio3.00
Quick ratio2.23
Total debt/total equity0.0747
Total debt/total capital0.0695
More ▼

Growth rates in USD

SmartText is unavailable
Div yield(5 year avg)0.23%
Div growth rate (5 year)6.20%
Payout ratio (TTM)8.95%
EPS growth(5 years)23.79
EPS (TTM) vs
TTM 1 year ago
-8.55
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.